UNIGE document Scientific Article
previous document  unige:1975  next document
add to browser collection

Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma

Murat, Anastasia
Gorlia, Thierry
Lambiv, Wanyu L.
Shay, Tal
Hamou, Marie-France
Regli, Luca
show hidden authors show all authors [1 - 20]
Published in Journal of Clinical Oncology. 2008, vol. 26, no. 18, p. 3015-24
Abstract PURPOSE: Glioblastomas are notorious for resistance to therapy, which has been attributed to DNA-repair proficiency, a multitude of deregulated molecular pathways, and, more recently, to the particular biologic behavior of tumor stem-like cells. Here, we aimed to identify molecular profiles specific for treatment resistance to the current standard of care of concomitant chemoradiotherapy with the alkylating agent temozolomide. PATIENTS AND METHODS: Gene expression profiles of 80 glioblastomas were interrogated for associations with resistance to therapy. Patients were treated within clinical trials testing the addition of concomitant and adjuvant temozolomide to radiotherapy. RESULTS: An expression signature dominated by HOX genes, which comprises Prominin-1 (CD133), emerged as a predictor for poor survival in patients treated with concomitant chemoradiotherapy (n = 42; hazard ratio = 2.69; 95% CI, 1.38 to 5.26; P =.004). This association could be validated in an independent data set. Provocatively, the HOX cluster was reminiscent of a "self-renewal" signature (P =.008; Gene Set Enrichment Analysis) recently characterized in a mouse leukemia model. The HOX signature and EGFR expression were independent prognostic factors in multivariate analysis, adjusted for the O-6-methylguanine-DNA methyltransferase (MGMT) methylation status, a known predictive factor for benefit from temozolomide, and age. Better outcome was associated with gene clusters characterizing features of tumor-host interaction including tumor vascularization and cell adhesion, and innate immune response. CONCLUSION: This study provides first clinical evidence for the implication of a "glioma stem cell" or "self-renewal" phenotype in treatment resistance of glioblastoma. Biologic mechanisms identified here to be relevant for resistance will guide future targeted therapies and respective marker development for individualized treatment and patient selection.
Keywords AdultAdult Stem Cells/pathologyAgedAntineoplastic Agents, Alkylating/therapeutic useBrain Neoplasms/enzymology/genetics/pathology/therapyCombined Modality TherapyDacarbazine/analogs & derivatives/therapeutic useDrug Resistance, NeoplasmGene Expression ProfilingGenes, HomeoboxGlioblastoma/enzymology/genetics/pathology/therapyHumansMiddle AgedMultigene FamilyRadiation ToleranceReceptor, Epidermal Growth Factor/biosynthesis/genetics
PMID: 18565887
Full text
Article (Author postprint) (1.5 MB) - document accessible for UNIGE members only Limited access to UNIGE
Other version: http://jco.ascopubs.org/cgi/content/full/26/18/3015
Research group Immunothérapie des cancers (42)
(ISO format)
MURAT, Anastasia et al. Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. In: Journal of Clinical Oncology, 2008, vol. 26, n° 18, p. 3015-24. https://archive-ouverte.unige.ch/unige:1975

262 hits



Deposited on : 2009-06-11

Export document
Format :
Citation style :